Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Digestive and Liver Disease

• Publication date

  2008-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.DLD.2007.10.019PMID 18083083
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD)

  2007cited by this paper
• 87 Prediction of liver fibrosis in non-alcoholic steatohepatitis (NASH): Risk factors and diagnostic potential of liver elasticity using fibroscan

  2006cited by this paper
• Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations

  2006cited by this paper
• Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C

  2005cited by this paper
• Nonalcoholic fatty liver disease

  2005cited by this paper
• Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease.

  2005cited by this paper
• Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

  2005cited by this paper
• Sampling variability of liver biopsy in nonalcoholic fatty liver disease.

  2005cited by this paper
• Efficacy of non-invasive elastometry on staging of hepatic fibrosis.

  2004cited by this paper
• Sampling variability of liver fibrosis in chronic hepatitis C

  2003cited by this paper
• Non‐alcoholic steatohepatitis: What is it, and why is it important in the Asia–Pacific region?

  2003cited by this paper
• Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

  2003cited by this paper
• Nonalcoholic fatty liver disease.

  2002cited by this paper
• AGA technical review on nonalcoholic fatty liver disease.

  2002cited by this paper
• [Good clinical practice guidelines for fine needle aspiration biopsy of the liver: past, present and future].

  2002cited by this paper
• Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

  2002cited by this paper
• [Good clinical practice guidelines for fine needle aspiration biopsy of the liver: past, present and future].

  2002influential reference
• Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

  2002cited by this paper
• Nonalcoholic steatohepatitis: risk factors for liver fibrosis.

  2002cited by this paper
• Shear elasticity probe for soft tissues with 1-D transient elastography

  2002cited by this paper
• Treatment of non‐alcoholic fatty liver disease

  2002cited by this paper
• Nonalcoholic Steatohepatitis: Definition and Pathology

  2001cited by this paper
• Liver biopsy.

  2001cited by this paper
• The role of liver biopsy in chronic hepatitis C

  2001cited by this paper
• Liver fibrosis in overweight patients.

  2000cited by this paper
• Appropriateness of liver biopsy.

  2000cited by this paper
• Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis

  1999cited by this paper
• Abdominal fat: standardized technique for measurement at CT.

  1999cited by this paper
• Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

  1999cited by this paper
• Serum type III procollagen peptide, type IV collagen 7S domain, central triple‐helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: Relationship to liver histology

  1994cited by this paper
• Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C.

  1994cited by this paper
• Significance of serum type-IV collagen levels in various liver diseases. Measurement with a one-step sandwich enzyme immunoassay using monoclonal antibodies with specificity for pepsin-solubilized type-IV collagen.

  1992cited by this paper
• Serum hyaluronan and aminoterminal propeptide of type III procollagen: variation with age.

  1992cited by this paper
• Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury.

  1988cited by this paper
• Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver.

  1986cited by this paper
• [Mechanical properties of living tissues].

  1986cited by this paper
• Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.

  1980influential reference
• Sampling variability on percutaneous liver biopsy.

  1979cited by this paper
• Letter: the consultants' contract.

  1975cited by this paper
• Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy

  1971cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowncited by this paper

• Investigating confounding factors in shear wave speed measurements of fibrotic liver tissues: a computer simulation study.

  2026cites this paper
• Bedside FibroScan as a Point-of-care Tool for Quantification for Cirrhosis: A Single-center Prospective Observational Study from Western India.

  2025cites this paper
• Comparing FIB-4, VCTE, pSWE, 2D-SWE, and MRE Thresholds and Diagnostic Accuracies for Detecting Hepatic Fibrosis in Patients with MASLD: A Systematic Review and Meta-Analysis

  2025cites this paper
• Utilizing Altmetrics to Track Advancements in Noninvasive Tests for MASLD

  2025cites this paper
• Metabolic-associated fatty liver disease: Noninvasive diagnosis and assessment of liver fibrosis

  2025cites this paper
• Defining optimal fatty liver index thresholds for MASLD and MetALD using controlled attenuation parameter as reference

  2025cites this paper
• Diagnostic accuracy of transient elastography in MASLD is independent of MRI-PDFF steatosis in a multicenter study

  2025cites this paper
• Prevalence of Hepatic Fibrosis and Performance of Non-invasive Liver Fibrosis Scores in an Eastern Indian Diabetic Population with NAFLD

  2025influential citation
• Unveiling the Silent Threat: Metabolic Dysfunction-Associated Steatotic Liver Disease Risk in Young Adults Through Noninvasive Assessment

  2025cites this paper
• 3D microscaffolds with triple-marker sensitive nanoprobes for studying fatty liver disease in vitro.

  2024cites this paper
• Changes in Transient Elastography with Glucagon-Like Peptide-1 Receptor Agonist Use in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Real-World Retrospective Analysis

  2024cites this paper
• Association between sleep apnea and ultrasound-defined liver fibrosis: Results from NHANES 2017 to 2020

  2024cites this paper
• Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis

  2024cites this paper
• A Prospective Randomised Comparative Four-arm Intervention Study of Efficacy and Safety of Saroglitazar and Vitamin E in Patients With Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH)-SVIN TRIAL.

  2024cites this paper
• Association of Serum Malondialdehyde Levels with Lipid Profile and Liver Function in Patients with Inflammatory Bowel Disease

  2024influential citation
• Imaging-based non-invasive liver disease assessment for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline.

  2024cites this paper
• Serum Cytokeratin 18 Fragment Is an Indicator for Treating Metabolic Dysfunction-Associated Steatotic Liver Disease

  2024cites this paper
• Miniaturized Liver Disease Mimics to Gain Insights into MMP Expression during Disease Progression.

  2024cites this paper
• Liver Fibrosis Index-4 Does Not Correlate to Liver Elastography in Patients with Inflammatory Bowel Disease

  2024influential citation
• Liver Stiffness and Fibrosis Used as Early Diagnosis of Patients with Chronic Liver Disease in A Retrospective Cross-Sectional Study

  2024cites this paper
• AST/ALT ratio, APRI, and FIB-4 compared to FibroScan for the assessment of liver fibrosis in patients with chronic hepatitis B in Bandar Abbas, Hormozgan, Iran

  2023cites this paper
• Simple proxies of insulin resistance identify obese metabolic dysfunction‐associated fatty liver disease subjects with advanced liver disease

  2023cites this paper
• Validation of the utility of Agile scores to identify advanced fibrosis and cirrhosis in Japanese patients with nonalcoholic fatty liver disease

  2023cites this paper
• Effect of Canagliflozin on liver steatosis in obese non diabetic patients with non-alcoholicfatty liver disease: A double blind randomized controlled trial

  2023cites this paper
• Comparison of strain elastography and shear wave elastography in diagnosis of fibrosis in nonalcoholic fatty liver disease

  2023cites this paper
• T-HAD Score: A Novel Diagnostic Model for Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease (NAFLD)

  2023cites this paper
• Time-Restricted Fasting Improves Liver Steatosis in Non-Alcoholic Fatty Liver Disease—A Single Blinded Crossover Trial

  2023cites this paper
• Performance of FibroScan in grading steatosis and fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis.

  2023cites this paper
• Ultrasound Based Elastography Techniques for the Evaluation of Nonalcoholic Liver Disease

  2023cites this paper
• A sequential approach using the age‐adjusted fibrosis‐4 index and vibration‐controlled transient elastography to detect advanced fibrosis in Korean patients with non‐alcoholic fatty liver disease

  2022cites this paper
• Validation of the accuracy of the FAST™ score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithms

  2022cites this paper
• Liver Stiffness Measurements by 2D Shear-Wave Elastography: Effect of Steatosis on Fibrosis Evaluation.

  2022cites this paper
• Validation and Performance of FibroScan®-AST (FAST) Score on a Brazilian Population with Nonalcoholic Fatty Liver Disease

  2022cites this paper
• A 3-step approach to predict advanced fibrosis in nonalcoholic fatty liver disease: impact on diagnosis, patient burden, and medical costs

  2022cites this paper
• SWOT analysis of noninvasive tests for diagnosing NAFLD with severe fibrosis: an expert review by the JANIT Forum

  2022cites this paper
• Non-invasive methods to evaluate liver fibrosis in patients with non-alcoholic fatty liver disease

  2022cites this paper
• Diagnostic accuracy of transient elastography and two-dimensional shear wave elastography for staging liver fibrosis in children or adolescents: A systematic review and meta-analysis.

  2022cites this paper
• Liver stiffness (Fibroscan®) is a predictor of all‐cause mortality in people with non‐alcoholic fatty liver disease

  2022cites this paper
• Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis

  2022cites this paper
• Simultaneously Screening for Liver Steatosis and Fibrosis in Romanian Type 2 Diabetes Mellitus Patients Using Vibration-Controlled Transient Elastography with Controlled Attenuation Parameter

  2022cites this paper
• Diagnostic comparison of vibration-controlled transient elastography and MRI techniques in overweight and obese patients with NAFLD

  2022cites this paper
• nHow histopathologic changes in pediatric nonalcoholic fatty liver diseases influence in vivo liver stiffness.

  2021cites this paper
• Nonalcoholic Fatty Liver Disease

  2021cites this paper
• Comparison between non-invasive methods and liver histology to stratify liver fibrosis in obese patients submitted to bariatric surgery.

  2021cites this paper
• Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand?

  2021cites this paper
• Ultrasonographic index for the diagnosis of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease.

  2021cites this paper
• Intriguing findings of liver fibrosis following COVID-19

  2021cites this paper
• How Good Is Trans Abdominal Ultrasound for Evaluating NAFLD in the General Population? A Cross-Sectional Study

  2021cites this paper
• Validation of a two‐step approach combining serum biomarkers and liver stiffness measurement to predict advanced fibrosis

  2021cites this paper
• The Association between Low Muscle Mass and Hepatic Steatosis in Asymptomatic Population in Korea

  2021cites this paper
• Insulin Resistance Is Not Increased in Inflammatory Bowel Disease Patients but Is Related to Non-Alcoholic Fatty Liver Disease

  2021cites this paper
• A nutritional intervention that promotes increased vegetable intake in Japanese with non-alcoholic fatty liver disease: a six-month trial

  2021cites this paper
• Liver Stiffness Measurement by Fibroscan in Patients With Hepatitis B

  2021cites this paper
• Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis.

  2021cites this paper
• Porphyran‐derived oligosaccharides alleviate NAFLD and related cecal microbiota dysbiosis in mice

  2021cites this paper
• Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis

  2021cites this paper
• Effect of sodium-glucose cotransporter 2 inhibitor in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a propensity score-matched analysis of real-world data

  2021cites this paper
• Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for the Diagnosis of Liver Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease

  2021cites this paper
• The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases

  2021cites this paper
• Stéatopathie non alcoolique

  2020cites this paper
• The Role of Elastography in Non-Alcoholic Fatty Liver Disease

  2020cites this paper
• Diagnostic Accuracy of FibroScan and Factors Affecting Measurements

  2020cites this paper
• Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity

  2020influential citation
• Non-invasive Assessment of Non-alcoholic Fatty Liver Disease: Ultrasound and Transient Elastography

  2020cites this paper
• Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Step Forward for Better Evaluation Using Ultrasound Elastography

  2020cites this paper
• Introduction to Fibrosis Assessment by Liver Stiffness in Different Etiologies

  2020cites this paper
• Epidemiology, Pathogenesis, and Diagnostic Strategy of Diabetic Liver Disease in Japan

  2020cites this paper
• Advances in ultrasound elastography for nonalcoholic fatty liver disease

  2020cites this paper
• Elastography Techniques for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease

  2020cites this paper
• Identification of Patients with Advanced Fibrosis Due to Nonalcoholic Fatty Liver Disease: Considerations for Best Practice.

  2020cites this paper
• Spectrum of liver diseases in patients referred for Fibroscan: A single center experience in the Middle East

  2020cites this paper
• Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Cirrhosis Confirmed by Liver Histology after 14 Years

  2020cites this paper
• Non‐invasive diagnosis of non‐alcoholic steatohepatitis and advanced fibrosis in Japan: A targeted literature review

  2020cites this paper
• Accuracy of the Enhanced Liver Fibrosis test, and combination of the Enhanced Liver Fibrosis and non‐invasive tests for the diagnosis of advanced liver fibrosis in patients with non‐alcoholic fatty liver disease

  2020cites this paper
• A pragmatic non-invasive assessment of liver fibrosis in patients with psoriasis, rheumatoid arthritis or Crohn's disease receiving methotrexate therapy.

  2020cites this paper
• What does liver elastography measure? Technical aspects and methodology.

  2020cites this paper
• Estimated Prevalence of Advanced Hepatic Fibrosis by Elastography in Patients with Type 2 Diabetes

  2020cites this paper
• Patient Specific Biomechanics Are Clinically Significant In Accurate Computer Aided Surgical Image Guidance

  2020cites this paper
• Elastin‐Like Recombinamers: Deconstructing and Recapitulating the Functionality of Extracellular Matrix Proteins Using Recombinant Protein Polymers

  2020cites this paper
• The Relevance of Noninvasive Tools To Assess Fibrosis in Non-Alcoholic Fatty Liver Disease.

  2020cites this paper
• The performance of M and XL probes of FibroScan for the diagnosis of steatosis and fibrosis on a Brazilian nonalcoholic fatty liver disease cohort

  2020cites this paper
• Positive Pattern Recognition System Using Alanine Aminotransferase, Type IV Collagen 7s, and E Value (Liver Stiffness) for the Diagnosis of Nonalcoholic Steatohepatitis Based on Natural History

  2020cites this paper
• Diagnostic accuracy of FibroScan‐AST score to identify non‐alcoholic steatohepatitis with significant activity and fibrosis in Japanese patients with non‐alcoholic fatty liver disease: Comparison between M and XL probes

  2020cites this paper
• Modeling Steatohepatitis in Humans with Pluripotent Stem Cell-Derived Organoids.

  2019cites this paper
• Assessment of Liver Fibrosis With Elastography Point Quantification vs Other Noninvasive Methods

  2019cites this paper
• Accuracy of liver stiffness measurement and controlled attenuation parameter using FibroScan® M/XL probes to diagnose liver fibrosis and steatosis in patients with nonalcoholic fatty liver disease: a multicenter prospective study

  2019cites this paper
• Effects of dapagliflozin in type 2 diabetes patients with fatty liver

  2019cites this paper
• High prevalence of nonalcoholic steatohepatitis and abnormal liver stiffness in a young and obese Mexican population

  2019cites this paper
• Usefulness of Transient Elastography for Non-Invasive Diagnosis of Liver Fibrosis in Pediatric Non-Alcoholic Steatohepatitis

  2019cites this paper
• Practical Use of Transient Elastography in Screening for Nonalcoholic Steatohepatitis in a Japanese Population

  2019cites this paper
• Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM Study

  2019cites this paper
• Assessment of 10‐year changes in liver stiffness using vibration‐controlled transient elastography in non‐alcoholic fatty liver disease

  2019cites this paper
• Noninvasive Assessment of Diffuse Liver Diseases Using Vibration-Controlled Transient Elastography (VCTE)

  2019cites this paper
• Systematic Review: Noninvasive Assessments of Intestinal Failure-Associated Liver Disease in the Adult Population.

  2019cites this paper
• Comparison of Acoustic Structure Quantification, Transient Elastography (FibroScan) and Histology in Patients with Chronic Hepatitis B and without Moderate to Severe Hepatic Steatosis.

  2019cites this paper
• Fuzzy Inference System

  2019cites this paper
• Noninvasive Tests of Liver Fibrosis

  2019cites this paper
• When the liver gets stiff, the tough get moving

  2019cites this paper
• Pediatric NAFLD: an overview and recent developments in diagnostics and treatment

  2019cites this paper
• Effect of diet-induced weight loss on cytokeratin-18 levels in overweight and obese patients with liver fibrosis.

  2019cites this paper